
|Articles|February 7, 2020
5 Reasons to Join the Pharmacist Moms Database
Author(s)Suzanne Soliman, PharmD, BCMAS
The Pharmacist Moms Group has established a database for pharmacists that gives them access and visibility to help broaden their career opportunities.
Advertisement
Now pharmacists looking for ways to expand their careers and stand out from the competition might be getting some help. The Pharmacist Moms Group (PMG) has established a database for pharmacists that gives them access and visibility to help broaden their career opportunities. This database contains all types of roles from retail, hospital, and independent pharmacy to pharma industry, academia and others.
Here are 5 reasons you should join:
- It’s Free: Let’s face it, you have nothing to lose and everything to gain. Joining the PMG Database will give you more visibility, access to cool job opportunities, even side gigs and more.
- Earn Some Extra Cash: PMG conducts surveys for other companies interested in gaining insights and information from pharmacists. As a member of the PMG database, you can be eligible to earn money for participating in pharmacy related surveys and market research.
- We Appreciate Pharmacists: PMG is passionate about pharmacy! We value our partnership with the pharmacy community and are proud that PMG is the most engaged pharmacy organization in the U.S.
- Stay Competitive: Today’s job market is highly competitive. Finding quality recruiters can be challenging. With PMG, top level recruiters come to us to find talent. Broaden your opportunities today!
- Be in the Know: Database members will receive information on where they can earn free CE, discounts to PMG events, webinars and more to help you stay current in the pharmacy profession.
Visit
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Orforglipron Reduces Body Weight Up to 14% in Women at Every Stage of Menopause
2
Staging the Heart: NLA and EAS Reveal a New Era of Precision Lipidology and Imaging
3
Managing Grade 1 CRS in Patients With Follicular Lymphoma on Bispecific Antibodies: Home vs Health Care Facility Referred
4
New Evidence Positions Finerenone as Foundational Therapy Across the CKD Spectrum
5































































































































